Darifenacin
CAS 133099-04-4
Overview
Darifenacin is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010, the US rights were sold to Warner Chilcott for US$400 million
Anant Labs manufacture and furnish high quality Darifenacin impurities for global markets. Our Darifenacin EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.











